Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP375295.RAWC-ApVyRNycKtr5ZlJOl9OIacvdSisxQ4qoSoyijcIw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP375295.RAWC-ApVyRNycKtr5ZlJOl9OIacvdSisxQ4qoSoyijcIw130_assertion type Assertion NP375295.RAWC-ApVyRNycKtr5ZlJOl9OIacvdSisxQ4qoSoyijcIw130_head.
- NP375295.RAWC-ApVyRNycKtr5ZlJOl9OIacvdSisxQ4qoSoyijcIw130_assertion description "[Similar to other factors implicated in kidney cancer, FLCN has been shown to modulate activation of mammalian target of rapamycin (mTOR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375295.RAWC-ApVyRNycKtr5ZlJOl9OIacvdSisxQ4qoSoyijcIw130_provenance.
- NP375295.RAWC-ApVyRNycKtr5ZlJOl9OIacvdSisxQ4qoSoyijcIw130_assertion evidence source_evidence_literature NP375295.RAWC-ApVyRNycKtr5ZlJOl9OIacvdSisxQ4qoSoyijcIw130_provenance.
- NP375295.RAWC-ApVyRNycKtr5ZlJOl9OIacvdSisxQ4qoSoyijcIw130_assertion SIO_000772 22709692 NP375295.RAWC-ApVyRNycKtr5ZlJOl9OIacvdSisxQ4qoSoyijcIw130_provenance.
- NP375295.RAWC-ApVyRNycKtr5ZlJOl9OIacvdSisxQ4qoSoyijcIw130_assertion wasDerivedFrom befree-20140225 NP375295.RAWC-ApVyRNycKtr5ZlJOl9OIacvdSisxQ4qoSoyijcIw130_provenance.
- NP375295.RAWC-ApVyRNycKtr5ZlJOl9OIacvdSisxQ4qoSoyijcIw130_assertion wasGeneratedBy ECO_0000203 NP375295.RAWC-ApVyRNycKtr5ZlJOl9OIacvdSisxQ4qoSoyijcIw130_provenance.